Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 715

    1.

    Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.

    Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS.

    Ann Intern Med. 2005 Sep 20;143(6):415-26. Review.PMID: 16172440 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians.

    Gartlehner G, Gaynes BN, Hansen RA, Thieda P, DeVeaugh-Geiss A, Krebs EE, Moore CG, Morgan L, Lohr KN.

    Ann Intern Med. 2008 Nov 18;149(10):734-50. Review.PMID: 19017592 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis.

    Gartlehner G, Thieda P, Hansen RA, Gaynes BN, Deveaugh-Geiss A, Krebs EE, Lohr KN.

    Drug Saf. 2008;31(10):851-65. Review.PMID: 18759509 [PubMed - indexed for MEDLINE]Related articles

    4.

    Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis.

    Gartlehner G, Hansen RA, Carey TS, Lohr KN, Gaynes BN, Randolph LC.

    Int Clin Psychopharmacol. 2005 Mar;20(2):59-69.PMID: 15729080 [PubMed - indexed for MEDLINE]Related articles

    5.

    Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants.

    Hansen R, Gaynes B, Thieda P, Gartlehner G, Deveaugh-Geiss A, Krebs E, Lohr K.

    Psychiatr Serv. 2008 Oct;59(10):1121-30.PMID: 18832497 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Fluoxetine versus other types of pharmacotherapy for depression.

    Cipriani A, Brambilla P, Furukawa T, Geddes J, Gregis M, Hotopf M, Malvini L, Barbui C.

    Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004185. Review.PMID: 16235353 [PubMed - indexed for MEDLINE]Related articles

    7.

    The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.

    Bauer M, Tharmanathan P, Volz HP, Moeller HJ, Freemantle N.

    Eur Arch Psychiatry Clin Neurosci. 2009 Apr;259(3):172-85. Epub 2009 Jan 22.PMID: 19165525 [PubMed - indexed for MEDLINE]Related articles

    8.

    Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.

    Kennedy SH, Andersen HF, Lam RW.

    J Psychiatry Neurosci. 2006 Mar;31(2):122-31. Erratum in: J Psychiatry Neurosci. 2006 Jul;31(4):228. PMID: 16575428 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.

    Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA.

    JAMA. 2007 Apr 18;297(15):1683-96.PMID: 17440145 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Treatment of depression--newer pharmacotherapies.

    Mulrow CD, Williams JW Jr, Trivedi M, Chiquette E, Aguilar C, Cornell JE, Badgett R, Noël PH, Lawrence V, Lee S, Luther M, Ramirez G, Richardson WS, Stamm K.

    Psychopharmacol Bull. 1998;34(4):409-795. Review.PMID: 10513454 [PubMed - indexed for MEDLINE]Related articles

    11.

    Milnacipran versus other antidepressive agents for depression.

    Nakagawa A, Watanabe N, Omori IM, Barbui C, Cipriani A, McGuire H, Churchill R, Furukawa TA.

    Cochrane Database Syst Rev. 2009 Jul 8;(3):CD006529. Review.PMID: 19588396 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Use of antidepressant drugs in schizophrenic patients with depression]

    Micallef J, Fakra E, Blin O.

    Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French. PMID: 16910628 [PubMed - indexed for MEDLINE]Related articles

    13.

    Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.

    Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA; Multiple Meta-Analyses of New Generation Antidepressants (MANGA) Study Group.

    J Clin Psychiatry. 2008 Sep;69(9):1404-15. Review.PMID: 19193341 [PubMed - indexed for MEDLINE]Related articles

    14.

    Sertraline versus other antidepressive agents for depression.

    Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, McGuire H, Barbui C.

    Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006117. Review.PMID: 19370626 [PubMed - indexed for MEDLINE]Related articles

    15.

    Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: a meta-analysis of randomized clinical trials.

    Vis PM, van Baardewijk M, Einarson TR.

    Ann Pharmacother. 2005 Nov;39(11):1798-807. Epub 2005 Sep 27.PMID: 16189284 [PubMed - indexed for MEDLINE]Related articles

    16.

    The efficacy of antidepressants in the treatment of depression in dementia.

    Bains J, Birks JS, Dening TR.

    Cochrane Database Syst Rev. 2002;(4):CD003944. Review.PMID: 12519625 [PubMed - indexed for MEDLINE]Related articles

    17.

    Escitalopram in the treatment of major depressive disorder: a meta-analysis.

    Kennedy SH, Andersen HF, Thase ME.

    Curr Med Res Opin. 2009 Jan;25(1):161-75.PMID: 19210149 [PubMed - indexed for MEDLINE]Related articles

    19.

    Efficacy and tolerability of second-generation antidepressants in social anxiety disorder.

    Hansen RA, Gaynes BN, Gartlehner G, Moore CG, Tiwari R, Lohr KN.

    Int Clin Psychopharmacol. 2008 May;23(3):170-9. Review.PMID: 18408531 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis.

    Gartlehner G, Thaler K, Hansen RA, Gaynes BN.

    Drug Saf. 2009;32(12):1159-73. doi: 10.2165/11318930-000000000-00000.PMID: 19916583 [PubMed - in process]Related articles

    Supplemental Content

    Find related data